日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

接受自体细胞毒性T淋巴细胞治疗的淋巴瘤患者,其靶向Epstein-Barr病毒潜伏膜蛋白,可获得持续完全缓解。

Bollard, Catherine M; Gottschalk, Stephen; Torrano, Vicky; Diouf, Oumar; Ku, Stephanie; Hazrat, Yasmin; Carrum, George; Ramos, Carlos; Fayad, Luis; Shpall, Elizabeth J; Pro, Barbara; Liu, Hao; Wu, Meng-Fen; Lee, Daniel; Sheehan, Andrea M; Zu, Youli; Gee, Adrian P; Brenner, Malcolm K; Heslop, Helen E; Rooney, Cliona M

Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4

通过靶向上调的MAGE-A4改善复发性EBV阴性霍奇金淋巴瘤的T细胞疗法

Cruz, Conrad R; Gerdemann, Ulrike; Leen, Ann M; Shafer, Jessica A; Ku, Stephanie; Tzou, Benjamin; Horton, Terzah M; Sheehan, Andrea; Copeland, Amanda; Younes, Anas; Rooney, Cliona M; Heslop, Helen E; Bollard, Catherine M

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

扩增靶向巨细胞病毒、EB病毒和腺病毒多种抗原的T细胞,以在干细胞移植后提供广泛的抗病毒特异性

Hanley, Patrick J; Shaffer, Donald R; Cruz, Conrad R Y; Ku, Stephanie; Tzou, Benjamin; Liu, Hao; Demmler-Harrison, Gail; Heslop, Helen E; Rooney, Clio M; Gottschalk, Stephen; Bollard, Catherine M

Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.

抗原特异性细胞毒性 T 淋巴细胞可以靶向霍奇金淋巴瘤中对化疗耐药的侧群肿瘤细胞

Shafer Jessica A, Cruz Conrad R, Leen Ann M, Ku Stephanie, Lu An, Rousseau Alexandra, Heslop Helen E, Rooney Cliona M, Bollard Catherine M, Foster Aaron E